Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Integrating new migraine treatments into clinical practice (part 1) : management of acute migraine attack].

Revue medicale de Liege·2023
Same author

Monoclonal antibodies blocking CGRP transmission: An update on their added value in migraine prevention.

Revue neurologique·2020
Same author

About a case of Wernicke's encephalopathy after sleeve gastrectomy.

Eating and weight disorders : EWD·2016
Same author

One-year prevalence of migraine using a validated extended French version of the ID Migraine™: A Belgian population-based study.

Revue neurologique·2015
Same author

Analysis and clinical correlates of 20 Hz photic driving on routine EEG in migraine.

Acta neurologica Belgica·2014
Same author

Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes?

Cephalalgia : an international journal of headache·2014

Related Experiment Video

Updated: Jul 3, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

[Migraine management: current trends and future prospects].

A Fumal1, P Y Gérardy, J Schoenen

  • 1Service Uni- versitaire de Neurologie, Unité de Recherches sur les Céphalées, Hôpital de la Citadelle, Liège, Belgique. Arnaud.Fumal@chu.ulg.ac.be

Revue Medicale De Liege
|August 2, 2008
PubMed
Summary

Migraine is common but often underdiagnosed and undertreated, despite new treatment options. Personalized treatment plans are crucial for improving patient outcomes and satisfaction in migraine management.

More Related Videos

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies
05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Related Experiment Videos

Last Updated: Jul 3, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies
05:49

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Migraine presents a significant individual and societal burden, yet remains underdiagnosed and undertreated.
  • Current management options for migraine have expanded, offering various pharmacological classes and delivery routes for acute and preventive therapies.

Purpose:

  • To summarize migraine phenotypic presentations.
  • To review current recommendations for acute and preventive migraine treatment.
  • To highlight recent advances relevant to clinical diagnosis and management.

Summary:

  • Despite expanded treatment options, many migraine patients experience low disability and satisfaction due to accessibility, optimization, efficacy, or tolerability issues.
  • Effective migraine management requires individualized treatment tailored to patient-specific factors like subtype, disability, history, expectations, and comorbidities.
  • There is a continued need for improved patient education and more efficient therapeutic strategies in migraine care.

Impact:

  • Enhancing clinical practice through updated diagnostic and management strategies for migraine.
  • Improving patient outcomes and satisfaction by addressing current treatment gaps.
  • Contributing to a better understanding of personalized medicine approaches in neurological disorders.